An approach to analysis of radiolabeled ligand interactions with specific receptors

European Journal of Pharmacology

Volumn 386, Issue 2-3, 1999, Pages 279-288

  Manukhin, Boris N ^a   Nesterova, Larisa A ^a   Smurova, Elena A ^a   Kichikulova, Tasegul P ^a  

^a KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

Author keywords

Adrenoceptor; Muscarinic acetylcholine receptor; Radioligand binding

Indexed keywords

BETA ADRENERGIC RECEPTOR; DIHYDROALPRENOLOL; MUSCARINIC RECEPTOR; PROPRANOLOL; QUINUCLIDINYL BENZILATE; RADIOLIGAND;

ANIMAL CELL; ARTICLE; BINDING SITE; BRAIN CORTEX; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CEREBRAL CORTEX; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; LIGANDS; MALE; MUSCARINIC ANTAGONISTS; PROPRANOLOL; QUINUCLIDINYL BENZILATE; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, MUSCARINIC; SYNAPTOSOMES; TRITIUM;

EID: 0033385553     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00679-2     Document Type: Article

References (39)

1. 3H]Quinuclidinyl benzilate. Mol. Pharmacol. 2(2):1982;304-309.
2. Andre C., Vauquelin G., De Backer J.P., Strosberg A.D. Identification and chemical characterization of β-adrenergic receptors in intact turkey erythrocytes. Biochem. Pharmacol. 30:1981;2787-2795.
3. Anhaupl T., Liebl B., Remien J. Kinetic and equilibrium studies of iodo-cyanopindolol binding to β-adrenoreceptors on human lymphocytes: evidence for the existence of two classes of binding sites. J. Recept. Res. 8:1988;47-57.
4. Berrie C.P., Birdsall N.J.M., Burgen A.S.V., Hulme E.C. Guanine nucleotides modulate muscarinic receptor binding in the heart. Biophys. Res. Commun. 87:1979;1000-1005.
5. Brann M.R., Jorgensen H.B., Burstein E.S., Spalding T.A., Ellis J., Jones S.V.P., Hill-Eubanks D. Studies of the pharmacology, localization, and structure of muscarinic acetylcholine receptors. Higashida H., Yoshioka T., Mikoshiba K. Molecular Basis of Ion Channels and Receptors Involved in Nerve Excitation, Synaptic Transmission and Muscle Contraction. 1993;225-236 New York Academy of Sciences, New York.
6. Burgiser E., Lefkowitz R.J. Marangos P.J., Campbell I.C., Cohen R.M. β-Adrenergic Receptors in Brain Receptor Methodologics, Part A. 1984;230-258 Academic Press, New York.
7. Cheng Y.-C., Prusoff W.H. Relationship between the inhibition constants and the concentration of inhibitor which causes 50 percent inhibition of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
8. Chidiac P., Green M.A., Pawagi A.B., Wells J.W. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. Biochemistry. 36(24):1997;7361-7379.
9. Craig D.A. The Cheng-Prusoff relationship: something lost in the translation. Trends Pharmacol. Sci. 14:1993;89-91.
10. Dixon M., Webb E. Enzymes. 3:1982;813-1117 Moscow, Mir. (translated from English, in Russian).
11. Dunn S.M.J., Raftery M.A. Agonist binding to the Torpedo acetylcholine receptor. Biochemistry. 36(13):1997;3846-3853.
12. Feldman H.A. Mathematical theory of complex ligand-binding systems at: equilibrium: some methods for parameter fitting. Anal. Biochem. 48:1972;317-338.
13. 3H]Quinuclidinyl benzilate binding to muscarinic receptor in rat brain: comparison of results from intact brain slice and homogenates. Br. J. Pharmacol. 65:1979;451-456.
14. 3H]acetylcholine to m2 muscarinic receptors. Biochem. Pharmacol. 52:1996;1767-1775.
15. Haen E., Liebl B., Lederer T., Pliska V. Revised radioreceptor assay for β-adrenoceptors expressed on peripheral mononuclear leukocytes. J. Recept. Res. 11:1991;129-140.
16. Henn S.W., Henn F.A. The identification of subcellular fractions of the central nervous system. Lajtha A. Handbook of Neurochemistry. 1982;147-161 Plenum, New York.
17. Hieble J.P., Bondinell W.E. Jr., Ruffolo R.R. α and β-Adrenoceptors: from the gene to the clinic: 1. Molecular biology and adrenoceptor subclassification. J. Med. Chem. 38(18):1995;3416-3443.
18. Jarv J. A model of non-exclusive binding of agonist and antagonist on G-protein coupled receptors. J. Theor. Biol. 175:1995;577-582.
19. 2 on the membrane-bound muscarinic cholinoceptor in rat brain. Neyrokhimia. 3:1984;107-115. (in Russian).
20. Keleti T. Basic Enzyme Kinetics. 1990;350 Mir, Moscow. (translated from English, in Russian).
21. Klotz I.M., Hunston D.L. Properties of graphical representation of multiple classes of binding sites. Biochemistry. 10(16):1971;3065-3069.
22. Lazareno S., Birdsall N.J.M. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48(2):1995;362-378.
23. Leff P., Dougall I.G. Further concerns over Cheng-Prusoff analysis. Trends Pharmacol. Sci. 14:1993;110-112.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.I.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Manukhin B.N. Physiology of Adrenoceptors. 1968;350 Nauka, Moscow. (in Russian).
26. 1-adrenergic response of rat vas deferens smooth muscle. Fiziol. Zh. 76(7):1990;863-868. (in Russian).
27. 2-adrenoceptors on rat red cells. Dokl. Ross. Akad. Nauk. 332(3):1993;388-390. (in Russian).
28. Manukhin B.N., Nesterova L.A., Smurova E.A. Characteristics of the kinetics of interaction between β-adrenoceptors of rat erythrocytes and a specific blocker propranolol. Membr. Cell Biol. 8:1995;509-515.
29. Molinoff P.B., Wolfe B.B., Weiland G.A. Quantitative analysis of drug-receptor interactions: 2. Determination of the properties of receptor subtypes. Life Sci. 29:1981;427-443.
30. Munson P.J., Rodbard D. LIGAND: a versatile computerised approach for characterisation of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
31. 3H]quinuclidinyl benzylate binding to M-cholinoceptors on membranes from rat cerebral cortex. Dokl. Ross. Akad. Nauk. 343(2):1995;268-271. (in Russian).
32. Roffel A.F., Ensing K., Inthout W.G., Dezeeuw R.A., Zaagsma J. Heterogeneous receptor binding of classical quaternary muscarinic antagonists. Arch. Int. Pharmacol. Ther. 314:1991;90-104.
33. Sandnes D., Waelgaard J., Jacobsen S. Modes of determining β-adrenoceptor number in human mononuclear leukocytes. Pharmacol. Toxicol. 61:1987;265-270.
34. Severne Y., Kanarek L., Vauquelin G. Agonist-mediated conformational changes of β-adrenoceptors could occur independent of functional coupling to Ns. Naunyn-Schmiedeberg's Arch. Pharmacol. 332:1986;247-252.
35. 2-adrenoceptors on isolated membranes and intact red cells from rats. Ontogenes. 25(6):1994;42-46. (in Russian).
36. 1 adrenoceptor subtypes (high, low) in human benign prostatic hypertrophy tissue according to the affinities for prazosin. Prostate. 31:1997;216-222.
37. Tomoda A., Kodaira K., Taketo A., Tanimoto K., Yoneyama Y. Isolation of human erythrocyte membranes in glucose solution. Anal. Biochem. 140:1984;386-390.
38. Wreggett K.A., Wells J.W. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J. Biol. Chem. 270(38):1995;22488-22499.
39. Yamamura H.I., Snyder S.H. Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. U. S. A. 71:1974;1725-1729.